Lifecore Biomedical | 8-K: Current report
Lifecore Biomedical | 8-K: Current report
Lifecore Biomedical | 10-K: Annual report
Lifecore Biomedical | 8-K: Current report
Lifecore Biomedical | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-22NW Fund, LP(12.44%),22NW, LP(12.44%), etc.
Lifecore Biomedical | 8-K: Current report
Lifecore Biomedical | SCHEDULE 13G: Others
Lifecore Biomedical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dimensional Fund Advisors LP(0.0%)
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Schechter Joshua
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Calloway Nathaniel
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director OBUS NELSON
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director EDWARDS JEFFREY L
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Diradoorian Raymond H
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director HOUDE LOVAS KATRINA
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Barbarosh Craig A.
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Officer Morberg John D
Lifecore Biomedical | 8-K: Current report
Lifecore Biomedical | 4: Statement of changes in beneficial ownership of securities-Director Calloway Nathaniel
Lifecore Biomedical | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Lifecore Biomedical | 8-K: Current report
No Data